Paula Lum, MD, MPH

Professor of Clinical Medicine

Paula J. Lum, MD MPH is Professor of Clinical Medicine and founding Program Director of the UCSF Primary Care Addiction Medicine Fellowship. She has been a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at San Francisco General Hospital since 1999. Board certified in internal medicine and addiction medicine, Dr. Lum practices at the places where HIV, addiction, and poverty collide. Her research and clinical activities are grounded in evidence-based, patient-centered care to improve the health and well-being of the urban poor. Her current areas of focus include: (1) HIV and viral hepatitis prevention and treatment in persons who use drugs, (2) evidence-based interventions in primary care and non-traditional settings for unhealthy substance use and its complications, and (3) curricular interventions to provide health care professionals with the skills, knowledge, and confidence to offer effective patient-centered care to persons who use drugs.

Education
2019 - Diversity, Equity, and Inclusion Champion Training, University of California, San Francisco
Fellowship, 1999 - AIDS Prevention Studies, University of California, San Francisco
M.P.H., 1997 - Epidemiology, University of California, Berkeley
Residency, 1996 - Primary Care Internal Medicine, SFGH, University of California, San Francisco
M.D., 1993 - Medicine, Case Western Reserve University
B.A., 1985 - Human Biology, Stanford University
M.A., 1985 - Sociology, Stanford University
Honors and Awards
  • Meg Newman Award for Teaching Excellence, UCSF Division of HIV, Infectious Diseases & Global Medicine, 2024
  • John Murray Award for Academic Excellence and Dedication to the Mission of San Francisco General, San Francisco General Hospital Medical Services, 2021
  • W. Anderson Spickard, Jr. Excellence in Mentorship Award, Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA), 2019
  • Norman E. Zinberg Award for Achievement in the Field of Medicine, Drug Policy Alliance, 2019
  • Chancellor Award for Public Service, Faculty Nominee, University of California, San Francisco, 2018
  • Alpha Omega Alpha Honor Medical Society, Faculty Nominee, UCSF Chapter of AOA’s Class of 2011, 2011
  • Excellence in Direct Teaching and/or Excellence in Mentoring and Advising Award, Haile T. Debas Academy of Medical Educators, UCSF School of Medicine, 2007
  • Outstanding Teacher and Distinguished Lecturer Award, UCSF Division of HIV/AIDS at San Francisco General Hospital, 2000
  • Janet M. Glasgow Memorial Achievement Citation, American Medical Women’s Association, 1993
  • Alpha Omega Alpha Honor Medical Society, Case Western Reserve University School of Medicine, 1993
Websites
Publications

  1. Litwin AH, Tsui JI, Heo M, Mehta SH, Taylor LE, Lum PJ, Feinberg J, Kim AY, Norton BL, Pericot-Valverde I, Arnsten J, Meissner P, Karasz A, McKee MD, Ward JW, Johnson N, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Carty J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Groome M, Davies S, Costello K, Page K, HERO Study Group. Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study. JAMA network open 2024. PMID: 39186268


  2. Lopes SS, Pericot-Valverde I, Dotherow JE, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH, HERO study group. Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure. Drug and alcohol dependence 2024. PMID: 38991632


  3. Fokuo JK, Hutman PJ, Gruber VA, Masson CL, Lum PJ, Bush DM, Naugle JA, Sorensen JL. Substance use Attitudes, Beliefs, Experience, and Knowledge Among Nursing and Nursing Assistant Students. Journal of psychoactive drugs 2024. PMID: 38646910


  4. Lopes SS, Pericot-Valverde I, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH. Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study. BMC infectious diseases 2024. PMID: 38395747


  5. Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten J, Sprecht-Walsh S, Page K, Litwin AH, HERO Study Group, National Stakeholder Advisory Board. Optimal Hepatitis C Treatment Adherence Patterns and Sustained Virologic Response. among People Who Inject Drugs: The HERO Study. Journal of hepatology 2024. PMID: 38242324


  6. Lopes SS, Pericot-Valverde I, Arnsten J, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Moschella P, Heo M, Litwin AH. Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study. The International journal on drug policy 2023. PMID: 38103458


  7. Batchelder AW, Heo M, Foley JD, Sullivan MC, Lum P, Pericot Valverde I, Taylor LE, Mehta SH, Kim AY, Norton B, Tsui JI, Feinberg J, Page K, Litwin AH, HERO Study Group. Shame and stigma in association with the HCV cascade to cure among people who inject drugs. Drug and alcohol dependence 2023. PMID: 37951006


  8. Pericot-Valverde I, Lopes SS, Nahvi S, Thrasher JF, Karasz A, Taylor LE, Mehta SH, Lum PJ, Tsui JI, Page K, Feinberg J, Kim AY, Norton BL, Arnsten JH, Fernandez-Artamendi S, Heo M, Litwin A, HERO Research Group. Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study. Open forum infectious diseases 2023. PMID: 38023556


  9. Karasz A, Merchant K, Arnsten J, Feinberg J, Kim AY, Lum PJ, McKee MD, Mehta SH, Meissner P, Norton BL, Page K, Pericot-Valverde I, Singh R, Stein E, Taylor LE, Tsui JI, Wagner K, Litwin A. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences. Journal of medical Internet research 2023. PMID: 37266986


  10. Tsui JI, Lum PJ, Taylor LE, Mehta SH, Feinberg J, Kim AY, Norton BL, Niu J, Heo M, Arnsten J, Pericot-Valverde I, Thomas A, Blalock KL, Radick A, Murray-Krezan C, Page K, Litwin AH, HERO Study Group. Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs. Drug and alcohol dependence 2023. PMID: 37150144


  11. Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Roche J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Page K, HERO Study Group. Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. The lancet. Gastroenterology & hepatology 2022. PMID: 36370741


  12. Korthuis PT, Cook RR, Lum P, Waddell EN, Tookes H, Vergara-Rodriguez P, Kunkel LE, Lucas GM, Rodriguez A, Bielavitz S, Fanucchi L, Hoffman K, Bachrach K, Payne EH, Collins JA, Matthews A, Oden N, Jacobs P, Jelstrom E, Sorensen JL, McCarty D. HIV Clinic-Based Extended Release Naltrexone versus Treatment as Usual for People with HIV and Opioid Use Disorder: A Non-Blinded, Randomised Non-inferiority Trial. 2022. PMID: 35129242


  13. Perera R, Stephan L, Appa A, Giuliano R, Hoffman R, Lum P, Martin M. Meeting people where they are: implementing hospital-based substance use harm reduction. 2022. PMID: 35139877


  14. Hoffman KA, Baker R, Fanucchi LC, Lum PJ, Kunkel LE, Ponce Terashima J, McCarty D, Jacobs P, Korthuis PT. Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis. 2021. PMID: 34758887


  15. Cook RR, Torralva R, King C, Lum PJ, Tookes H, Foot C, Vergara-Rodriguez P, Rodriguez A, Fanucchi L, Lucas GM, Waddell EN, Korthuis PT. Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease. Drug and alcohol dependence 2021. PMID: 34600253


  16. Page K, Melia MT, Veenhuis RT, Winter M, Rousseau KE, Massaccesi G, Osburn WO, Forman M, Thomas E, Thornton K, Wagner K, Vassilev V, Lin L, Lum PJ, Giudice LC, Stein E, Asher A, Chang S, Gorman R, Ghany MG, Liang TJ, Wierzbicki MR, Scarselli E, Nicosia A, Folgori A, Capone S, Cox AL. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. The New England journal of medicine 2021. PMID: 33567193


  17. Hagle HN, Martin M, Winograd R, Merlin J, Finnell DS, Bratberg JP, Gordon AJ, Johnson C, Levy S, MacLane-Baeder D, Northup R, Weinstein Z, Lum PJ. Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction. Substance abuse 2021. PMID: 33465013


  18. Truong HM, Fatch R, Deeks SG, Krone M, Martin JN, Hunt PW, Lum PJ. Accumulation of HIV-1 Drug Resistance Mutations and Methamphetamine Use. Current HIV research 2021. PMID: 34176462


  19. Martin M, Snyder HR, Coffa D, Steiger S, Clement JP, Ranji SR, Azari S, Nguyen OK, Lum PJ. Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system. BMJ open quality 2021. PMID: 33500326


  20. Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, Korthuis PT. Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial. BMC health services research 2019. PMID: 31752905


  21. Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K. Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study. Contemporary clinical trials 2019. PMID: 31669450


  22. Carter J, Zevin B, Lum PJ. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addiction science & clinical practice 2019. PMID: 31060600


  23. Satterfield JM, Gregorich SE, Kalkhoran S, Lum PJ, Bloome J, Alvarado N, Muñoz RF, Vijayaraghavan M. Computer-Facilitated 5A's for Smoking Cessation: A Randomized Trial of Technology to Promote Provider Adherence. American journal of preventive medicine 2018. PMID: 29929682


  24. Mirzazadeh A, Evans JL, Hahn JA, Jain J, Briceno A, Shiboski S, Lum PJ, Bentsen C, Davis G, Shriver K, Dimapasoc M, Stone M, Busch MP, Page K. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. AIDS and behavior 2018. PMID: 29168067


  25. Hettema JE, Cockrell SA, Reeves A, Ingersoll KS, Lum PJ, Saitz R, Murray-Krezan CM, Carrejo VA. Development and differentiability of three brief interventions for risky alcohol use that include varying doses of motivational interviewing. Addiction science & clinical practice 2018. PMID: 29482632


  26. Page K, Cox A, Lum PJ. Opioids, Hepatitis C Virus Infection, and the Missing Vaccine. American journal of public health 2018. PMID: 29320280


  27. Dawson-Rose C, Draughon JE, Cuca Y, Zepf R, Huang E, Cooper BA, Lum PJ. Changes in Specific Substance Involvement Scores among SBIRT recipients in an HIV primary care setting. Addiction science & clinical practice 2017. PMID: 29229000


  28. Bruce RD, Merlin J, Lum PJ, Ahmed E, Alexander C, Corbett AH, Foley K, Leonard K, Treisman GJ, Selwyn P. 2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017. PMID: 29091230


  29. Simeone C, Shapiro B, Lum PJ. Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic. Addiction science & clinical practice 2017. PMID: 28826401


  30. Kalkhoran S, Alvarado N, Vijayaraghavan M, Lum PJ, Yuan P, Satterfield JM. Patterns of and reasons for electronic cigarette use in primary care patients. Journal of general internal medicine 2017. PMID: 28710596


  31. Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, Kral AH. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. The International journal on drug policy 2017. PMID: 28628854


  32. Vijayaraghavan M, Yuan P, Gregorich S, Lum P, Appelle N, Napoles AM, Kalkhoran S, Satterfield J. Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics. Preventive medicine reports 2017. PMID: 28271025


  33. Korthuis PT, Lum PJ, Vergara-Rodriguez P, Ahamad K, Wood E, Kunkel LE, Oden NL, Lindblad R, Sorensen JL, Arenas V, Ha D, Mandler RN, McCarty D. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial. Addiction (Abingdon, England) 2017. PMID: 28061017


  34. Todd Korthuis, Paula J. Lum, P. Vergara-Rodriguez, Keith Ahamad, Evan Wood, R. Lindblad, Raul Mandler, James Sorensen, Doan Ha, Neal Oden, Lynn Kunkel, Dennis McCarty. Extended-release naltrexone feasibility in HIV clinics: A pilot study. Drug and alcohol dependence 2017. PMID:


  35. Ahamad K, Korthuis PT, Lum PJ, Johnson C, Wood E. A delayed injection-site reaction in a patient receiving extended-release naltrexone. Substance abuse 2016. PMID: 26820699


  36. Riley ED, Evans JL, Hahn JA, Briceno A, Davidson PJ, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. American journal of public health 2016. PMID: 26985620


  37. Paula J. Lum,R. Douglas Bruce. Comorbid substance use among persons with HIV and chronic pain. 2016. PMID:


  38. Dawson-Rose C, Draughon JE, Zepf R, Cuca YP, Huang E, Freeborn K, Lum PJ. Prevalence of Substance Use in an HIV Primary Care Safety Net Clinic: A Call for Screening. The Journal of the Association of Nurses in AIDS Care : JANAC 2015. PMID: 26763795


  39. . The longitudinal influence of multiple depressant use on nonfatal overdose among young people who inject drugs. 2015. PMID:


  40. Kalkhoran S, Appelle NA, Napoles AM, Munoz RF, Lum PJ, Alvarado N, Gregorich SE, Satterfield JM. Beyond the Ask and Advise: Implementation of a Computer Tablet Intervention to Enhance Provider Adherence to the 5As for Smoking Cessation. Journal of substance abuse treatment 2015. PMID: 26150093


  41. Dawson Rose C, Cuca YP, Kamitani E, Eng S, Zepf R, Draughon J, Lum P. Using Interactive Web-Based Screening, Brief Intervention and Referral to Treatment in an Urban, Safety-Net HIV Clinic. AIDS and behavior 2015. PMID: 25963770


  42. Soraya Azari, Neda Ratanawongsa, Jennifer Hettema, Caroline Cangelosi, Matt Tierney, Diana Coffa, Brad Shapiro, Sharad Jain, David Hersh, Jennifer Manuel, Daniel Ciccarone, Paula Lum. A Skills-Based Curriculum for Teaching Motivational Interviewing-Enhanced Screening, Brief Intervention, and Referral to Treatment (SBIRT) to Medical Residents. MedEdPORTAL 2015. PMID:


  43. Whittle AE, Buckelew SM, Satterfield JM, Lum PJ, O'Sullivan P. Addressing Adolescent Substance Use: Teaching Screening, Brief Intervention, and Referral to Treatment (SBIRT) and Motivational Interviewing (MI) to Residents. Substance abuse 2015. PMID: 25260121


  44. Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA internal medicine 2014. PMID: 25347412


  45. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ open 2014. PMID: 24875490


  46. Ratanawongsa N, Barton JL, Schillinger D, Yelin EH, Hettema JE, Lum PJ. Ethnically diverse patients' perceptions of clinician computer use in a safety-net clinic. Journal of health care for the poor and underserved 2013. PMID: 24185151


  47. McCance-Katz EF, Gruber VA, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD. Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. The American journal on addictions 2013. PMID: 24118434


  48. Gruber VA, Rainey PM, Lum PJ, Beatty GW, Aweeka FT, McCance-Katz EF. Interactions between alcohol and the HIV entry inhibitor Maraviroc. Journal of the International Association of Providers of AIDS Care 2013. PMID: 23881910


  49. McCance-Katz EF, Gruber VA, Beatty G, Lum PJ, Rainey PM. Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. Journal of addiction medicine 2013. PMID: 23666322


  50. Sara M. Buckelew, Amy Whittle, Paula Lum, Patricia O'Sullivan, Jason M. Satterfield. 8. Implementing Sbirt in Pediatrics: Results of a Needs Assessment. Journal of Adolescent Health 2013. PMID:


  51. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS care 2012. PMID: 23116051


  52. Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012. PMID: 23090930


  53. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. Volume 60 of Issue 3. Journal of acquired immune deficiency syndromes (1999) 2012. PMID: 22495786


  54. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. American journal of epidemiology 2012. PMID: 22227793


  55. Hettema JE, Ratanawongsa N, Manuel JK, Ciccarone D, Coffa D, Jain S, Lum PJ. A SBIRT curriculum for medical residents: development of a performance feedback tool to build learner confidence. Substance abuse 2012. PMID: 22738001


  56. Johnson MO, Dilworth SE, Stephens E, Lum PJ, Neilands TB. Expectancy and readiness-based predictors of treatment uptake among the urban poor living with HIV. Journal of acquired immune deficiency syndromes (1999) 2011. PMID: 21926630


  57. Dias PT, Hahn JA, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC infectious diseases 2011. PMID: 21810243


  58. Asher A, Lum PJ, Page K. Assessing candidacy for acute hepatitis C treatment among active young injection drug users: a case-series report. The Journal of the Association of Nurses in AIDS Care : JANAC 2011. PMID: 21497111


  59. Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG. Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone. Journal of acquired immune deficiency syndromes (1999) 2011. PMID: 21317592


  60. Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. Journal of acquired immune deficiency syndromes (1999) 2011. PMID: 21317590


  61. Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. Journal of acquired immune deficiency syndromes (1999) 2011. PMID: 21317600


  62. Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, Mitty J, Boverman J, Fiellin DA. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings. Journal of acquired immune deficiency syndromes (1999) 2011. PMID: 21317601


  63. Sullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. Journal of acquired immune deficiency syndromes (1999) 2011. PMID: 21317595


  64. Etcheverry MF, Lum PJ, Evans JL, Sanchez E, de Lazzari E, Mendez-Arancibia E, Sierra E, Gatell JM, Page K, Joseph J. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine 2011. PMID: 21241735


  65. Rose CD, Courtenay-Quirk C, Knight K, Shade SB, Vittinghoff E, Gomez C, Lum PJ, Bacon O, Colfax G. HIV intervention for providers study: a randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people. Volume 55 of Issue 5. Journal of acquired immune deficiency syndromes (1999) 2010. PMID: 20827218


  66. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn JA, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine 2010. PMID: 20638453


  67. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction (Abingdon, England) 2010. PMID: 20491725


  68. Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. The Journal of infectious diseases 2009. PMID: 19764883


  69. Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug and alcohol dependence 2009. PMID: 19181458


  70. Inglez-Dias A, Hahn JA, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug and alcohol review 2008. PMID: 18368610


  71. Lum PJ, Hahn JA, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. Journal of viral hepatitis 2008. PMID: 18233994


  72. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug and alcohol dependence 2007. PMID: 17980513


  73. Page-Shafer K, Hahn JA, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS (London, England) 2007. PMID: 17721105


  74. Colfax GN, Vittinghoff E, Grant R, Lum P, Spotts G, Hecht FM. Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS (London, England) 2007. PMID: 17197817


  75. Lum PJ, Tulsky JP. The medical management of opioid dependence in HIV primary care settings. Current HIV/AIDS reports 2006. PMID: 17089480


  76. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Volume 33 of Issue 4. Sexually transmitted diseases 2006. PMID: 16565643


  77. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. Volume 41 of Issue 1. Journal of acquired immune deficiency syndromes (1999) 2006. PMID: 16340470


  78. W. Kittikraisak, P. J. Davidson, J. A. Hahn, P. J. Lum, J. L. Evans, A. R. Moss, K. Page-Shafer. Incarceration among young injectors in San Francisco: associations with risk for hepatitis C virus infection. Journal of Substance Use 2006. PMID:


  79. Lum PJ, Sears C, Guydish J. Injection risk behavior among women syringe exchangers in San Francisco. Substance use & misuse 2005. PMID: 16253934


  80. Paula J. Lum, Kristen C. Ochoa, Judith A. Hahn, Kimberly Page Shafer, Jennifer L. Evans, Andrew R. Moss. LUM
    ET AL.
    RESPOND.     American journal of public health 2004. PMID:


  81. Lum PJ, Ochoa KC, Hahn JA, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. American journal of public health 2003. PMID: 12773355


  82. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of urban health : bulletin of the New York Academy of Medicine 2003. PMID: 12612103


  83. Shafer KP, Hahn JA, Lum PJ, Ochoa K, Graves A, Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. Journal of acquired immune deficiency syndromes (1999) 2002. PMID: 12447014


  84. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. The Journal of infectious diseases 2002. PMID: 12447730


  85. Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology (Baltimore, Md.) 2001. PMID: 11431749


  86. Clare Sears, Joseph R. Guydish, Erin K. Weltzien, Paula J. Lum. Investigation of a Secondary Syringe Exchange Program for Homeless Young Adult Injection Drug Users in San Francisco, California, U.S.A. JAIDS Journal of Acquired Immune Deficiency Syndromes 2001. PMID:


  87. Clare Sears, Joseph R. Guydish, Erin K. Weltzien, Paula J. Lum. Investigation of a Secondary Syringe Exchange Program for Homeless Young Adult Injection Drug Users in San Francisco, California, U.S.A. JAIDS Journal of Acquired Immune Deficiency Syndromes 2001. PMID: